Dr
Vivien
Verbrugge

Partner & Patent Attorney

Rennes Office

Telephone. +33672866728
Mobile. +33672866728
Email. [email protected]
Vcard
Linkedin

Experience

Vivien’s wealth of experience as an in-house attorney, advising at Management and Board level within global companies in multiple jurisdictions, makes him well placed to advise in-house IP and Legal Counsel in relation to IP opportunities and threats for both SMEs and multinationals. Vivien regularly advises clients on portfolio creation, infringement avoidance and freedom to commercialise, portfolio enforcement and dispute resolution matters. Vivien has also advised on multi-jurisdiction portfolio acquisitions, secured successful outcomes in EPO oppositions and coordinated many IP litigations.

Specialisms

  • Automotive systems
  • Baby & infant products
  • Construction
  • Drug delivery devices
  • Food and beverage packaging
  • Oil & gas
  • Renewable energy
  • Subsea technology
  • Testing, measurement and electronics

Industries

  • Automotive icon Automotive
  • Food & drink icon Food & drink
  • Retail icon Retail
  • Telecommunications icon Telecommunications

Services

  • Designs & design rights
  • Due diligence
  • IP litigation
  • Patent oppositions & appeals
  • Patents
  • Portfolio management
  • Searching & competitor monitoring
  • Strategy
  • Transactional IP & commercial support

Qualifications

Patent Attorney

European
French

MPHYS

Master in Physics & engineer degree

LLM

University of Strasbourg

OTHER

Vlerick management program

PHD

Physics, Optoectronics and Telecom

Related News

EPO Enlarged Board of Appeal decision G4/19 - a European patent application can be refused by reason of the prohibition on double patenting

The European Patent Office today confirmed in Decision G4/19 of the Enlarged board of Appeal that a European patent application can be refused for ‘double patenting’.  Such a refusal can …

Read article

Managing Intellectual Property IP Stars & Firm Rankings 2021

Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …

Read article

Medical technology most patented subject matter at EPO in 2020

Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …

Read article

The EPO ‘How To’ guide for antibody applications in Europe

The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …

Read article

Personalised drug patenting in Europe

Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …

Read article

The Internet of Medical Things

Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …

Read article

Covid-19 vaccine patent waivers

To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …

Read article

G1/21 hearing at the EPO

Follow this page for the updates from G1/21 hearing at the EPO on 28th May 2021. HGF Partners Dr Chris Moore and Douglas Drysdale will be reporting all the key …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us